💰 Business
Live
AstraZeneca and Axsome Therapeutics drive VanEck Pharmaceutical ETF down 1.8%
The VanEck Pharmaceutical ETF (PPH) fell 1.8% on Monday, driven by a 7.2% drop in AstraZeneca and a 4.6% decline in Axsome Therapeutics. This downturn reflects investor caution amid economic uncertain
Nasdaq News — 3 August 2026
Text:
29
0
0
The VanEck Pharmaceutical ETF (PPH) fell about 1.8% during Monday afternoon trading, making it one of the underperformers in the market. Key contribut
Read Full Story at Nasdaq News → Sources
💰 Business
CXMT becomes most valuable listed company in mainland China at 3.3 trillion yuan
💰 Business
Singapore stock market to open higher after Straits Times Index gains.
💰 Business
Anne Sweeney Resigns From Netflix Board After 11 Years
💰 Business
VWO and SPGM: Comparing Expense Ratios and Performance for Investors
💰 Business
Here Is Why Newsmax's Meta Partnership Could Accelerate the Path to Profitability for NMAX Stock.
💰 Business
Oil prices drop nearly 10% as U.S.-Iran fighting pauses
